Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Can-Fite BioPharma Ltd. (CANF) AI Dilution Summary

Updated Oct 6, 2026

Cash was $7,037,000 at 2026-06-30 against estimated monthly burn of $885,667. The most recent capital raised was a partly registered financing that closed 2026-09-03, with gross proceeds of $4,000,000 through placement agent H.C. Wainwright & Co., LLC, recorded as $3,570,047 net. The main source of dilution is the H.C. Wainwright & Co., LLC ATM program.